Tumour lysis syndrome complicating high‐dose treatment in patients with multiple myeloma

Tumour lysis syndrome (TLS), because of its low proliferative activity, is thought to only rarely complicate the treatment of patients with multiple myeloma. However, as more aggressive therapeutic approaches are increasingly used in the management of this disease, it is conceivable that clinicians...

Ausführliche Beschreibung